Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Readers Post 20 July Dividend Buys
11:47am, Wednesday, 23'rd Aug 2023
Prior to July 31, my readers mentioned 39 equities in their comments on my articles. Some bad news investments (Rogues) mixed with (mostly) Favorites. Thus, these are ReFa/Ro. Ten analyst-target-estim
7 Blue-Chip Bargains to Grab Now at Their All-Time Lows
07:00am, Wednesday, 23'rd Aug 2023
It's wise to always be on the lookout for the best blue-chip stock bargains. In the stock market, prices surge and plummet with every passing headline.
3 Pharma Stocks to Buy as Summer COVID Cases Spike
05:11am, Wednesday, 23'rd Aug 2023
Covid-19 related stocks started spiking again this week. Driven primarily by reports about new variants and increasing spread.
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
07:32pm, Tuesday, 22'nd Aug 2023
Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Covid Hospitalizations Jump. So Could Vaccine Demand.
01:17pm, Tuesday, 22'nd Aug 2023
Drugmakers like Pfizer and Moderna tamped down expectations. Now, cases are increasing.
U.S. Govt to Urge Citizens to Get New COVID-19 Shots
12:02pm, Tuesday, 22'nd Aug 2023
Shares of COVID-19 vaccine makers soared after reports suggest that the Biden administration will start a campaign urging citizens to vaccinate themselves with updated shots vaccine in the upcoming fa
FDA approves Pfizer's RSV vaccine to protect babies from RSV
11:52am, Tuesday, 22'nd Aug 2023
Pfizer (PFE) receives approval from the FDA on its vaccine for pregnant women to protect infants from RSV. Yahoo Finance Health Reporter Anjalee Khemlani explains the new vaccine and the outlook for f
FDA greenlights Pfizer's RSV vaccine to protect infants
10:51am, Tuesday, 22'nd Aug 2023
The U.S. Food and Drug Administration (FDA) has approved the first vaccine for pregnant individuals to prevent respiratory syncytial virus (RSV) in infants, Pfizer Inc (NYSE:PFE)'s Abrysvo.
Pfizer's (PFE) RSV Vaccine Gets FDA Nod for Pregnant Women
10:31am, Tuesday, 22'nd Aug 2023
The FDA approves Pfizer's (PFE) RSV vaccine, Abrysvo, for the prevention of lower respiratory tract disease in infants through administration to pregnant women.
Covid is going to be a problem for the stocks of vaccine makers, says Jefferies' Michael Yee
10:11am, Tuesday, 22'nd Aug 2023
Michael Yee, Jefferies senior biotech analyst, joins 'Squawk Box' to discuss the market performance of Covid vaccine stocks, as companies prepare to roll out new modified boosters to combat new varian
Down 25% In A Year Will Pfizer Stock Rebound To Its Pre-Inflation Shock Level?
07:00am, Tuesday, 22'nd Aug 2023
Returning to the pre-inflation shock level of over $60 means that PFE stock will have to gain more than 65% from here, and we don't think this will materialize anytime
FDA Approves First RSV Vaccine For Kids—Given To Pregnant Moms—Here's What To Know
05:57pm, Monday, 21'st Aug 2023
RSV infects nearly every child by the time they reach 2 and can cause serious, potentially fatal, illness.
Pfizer maternal RSV vaccine gets FDA approval
05:54pm, Monday, 21'st Aug 2023
A Pfizer Inc. PFE, +0.95% vaccine designed to protect babies from respiratory syncytial virus, or RSV, got a green light Monday from the U.S. Food and Drug Administration — a key milestone for infan
US FDA approves Pfizer's maternal RSV vaccine to protect infants
05:49pm, Monday, 21'st Aug 2023
The U.S. Food and Drug Administration on Monday approved Pfizer's respiratory syncytial virus (RSV) vaccine for use in women during the middle of the third trimester of pregnancy to protect their babi
FDA approves Pfizer maternal RSV vaccine for infants
05:43pm, Monday, 21'st Aug 2023
Pfizer hopes that its respiratory syncytial virus vaccine will be available to the public by the end of October or the beginning of November.
